Post-Translational Modifications of NTCP: A Regulatory Nexus for Bile Acid Transport and HBV Entry
Open Access
- 24 April 2026
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 14 (5) , 978
Abstract
The sodium-taurocholate cotransporting polypeptide (NTCP) plays a critical dual role in liver function: maintaining bile acid (BA) enterohepatic circulation and acting as a receptor for the entry of hepatitis B and D viruses into hepatocytes. This review outlines the impact of various post-translational modifications (PTMs) of NTCP—including phosphorylation, oligomerization, ubiquitination, and glycosylation—on its dynamic regulatory network. These modifications coordinate the modulation of NTCP’s membrane localization, stability, conformational state, and protein interactions, precisely controlling its functions in BA uptake and viral invasion. Targeting this PTM network presents a promising strategy for next-generation therapies that selectively inhibit viral infection while preserving BA transport, overcoming the limitations of conventional inhibitors that indiscriminately disrupt virus–NTCP interactions. By synthesizing recent insights into NTCP PTM research, this article highlights its role as a central regulator of its bifunctional properties and reveals potential avenues for precision therapies in viral hepatitis, cholestasis, and related liver diseases. However, most existing evidence is derived from in vitro or cell-based models, whereas in vivo studies and clinical validation remain limited; thus, the translational feasibility of strategies targeting post-translational modifications of NTCP still requires further investigation.Keywords
Funding Information
- National Natural Science Foundation of China (82575017)
This publication has 101 references indexed in Scilit:
- Phosphoinositides in membrane remodeling during infections and cellular stressesFEBS Letters, 2025
- Combination therapies for chronic hepatitis B in the era of emerging novel drugsHepatology International, 2025
- A novel synthetic bile acid derivative inhibits hepatitis B virus infection at entry step by interfering with the oligomerization of sodium taurocholate co-transporting polypeptideAntiviral Research, 2025
- Molecular mechanisms of hepatitis B virus entry inhibition by a bile acid derivative INT-767 binding to the preS1 regionAntiviral Research, 2025
- Bulevirtide: First ApprovalDrugs, 2020
- Age‐dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human liversHepatology Communications, 2018
- A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesHepatology, 2015
- Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)Hepatology, 2013
- Protein kinase C (PKC) participates in acetaminophen hepatotoxicity through c-jun-N-terminal kinase (JNK)-dependent and -independent signaling pathwaysHepatology, 2013
- PKC‐dependent endocytosis of the GLT1 glutamate transporter depends on ubiquitylation of lysines located in a C‐terminal clusterGlia, 2008